A naturalistic study of the effects of pharmacotherapy on substance use disorders among ADHD adults
- 12 March 2007
- journal article
- research article
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 37 (12) , 1743-1752
Abstract
Background: Studies of adults with attention deficit hyperactivity disorder (ADHD) show an elevated prevalence of substance use disorders (SUDs) and the substance abuse literature shows that ADHD is elevated in substance users. Some researchers postulate that stimulant treatment of ADHD increases the risk for SUD in ADHD patients but follow-up studies suggest treatment protects patients from subsequent SUDs. This report uses retrospective data to assess the impact of prior ADHD pharmacotherapy on SUDs in 206 ADHD adults (n=79 late-onset ADHD, n=127 full ADHD) grouped by lifetime history of ADHD treatment (no treatment, past treatment, current and past treatment).Method: Structured Clinical Interview for DSM-IV (SCID) data were used to establish abuse and dependence, and Drug Use Screening Inventory (DUSI) responses were used to establish prevalence of use, preference for cigarettes, alcohol and drugs of abuse, complications from use, and motivation for use (get high, change mood, sleep better).Results: No differences were found in the prevalence of cigarette smoking, alcohol or drug abuse or dependence, as well as no significant differences in 1-month prevalence of any use or use more than 20 times. No differences were found in complications of drug or alcohol use across groups. Subjects with current treatment rated getting high as a motivating factor significantly more frequently than subjects in the past treatment group; this result lost significance when we included ADHD diagnostic category.Conclusions: Our results are consistent across substances and ADHD diagnoses, and support the hypothesis that pharmacotherapy does not cause subsequent SUDs.Keywords
This publication has 22 references indexed in Scilit:
- Differential behavioral and neurochemical effects of cocaine after early exposure to methylphenidate in an animal model of attention deficit hyperactivity disorderBehavioural Brain Research, 2006
- Psychostimulant Treatment and Risk for Substance Abuse Among Young Adults with a History of Attention-Deficit/Hyperactivity Disorder: APopulation-Based, Birth Cohort StudyJournal of Child and Adolescent Psychopharmacology, 2005
- Rodent Models of Attention-Deficit/Hyperactivity DisorderBiological Psychiatry, 2005
- Attention-deficit/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk, and treatment issuesPsychiatric Clinics of North America, 2004
- Meta-Analysis of the Efficacy of Methylphenidate for Treating Adult Attention-Deficit/Hyperactivity DisorderJournal of Clinical Psychopharmacology, 2004
- The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder.Journal of Abnormal Psychology, 2002
- Transdermal Testosterone Treatment in Women with Impaired Sexual Function after OophorectomyNew England Journal of Medicine, 2000
- Childhood Inattention-Overactivity, Aggression, and Stimulant Medication History as Predictors of Young Adult OutcomesJournal of Child and Adolescent Psychopharmacology, 1999
- Prospective Study of Tobacco Smoking and Substance Dependencies Among Samples of ADHD and Non-ADHD ParticipantsJournal of Learning Disabilities, 1998
- History and significance of childhood attention deficit disorder in treatment-seeking cocaine abusersComprehensive Psychiatry, 1993